Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

c-kit gene mutation and CD117 expression in human anorectal melanomas.

Ni S, Huang D, Chen X, Huang J, Kong Y, Xu Y, Du X, Sheng W.

Hum Pathol. 2012 Jun;43(6):801-7. doi: 10.1016/j.humpath.2011.08.005. Epub 2011 Dec 9.

PMID:
22154054
2.

Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.

Willmore-Payne C, Holden JA, Tripp S, Layfield LJ.

Hum Pathol. 2005 May;36(5):486-93.

PMID:
15948115
3.

KIT gene mutations and copy number in melanoma subtypes.

Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, Town A, Harlow A, Cruz F 3rd, Azar S, Rubin BP, Muller S, West R, Heinrich MC, Corless CL.

Clin Cancer Res. 2008 Nov 1;14(21):6821-8. doi: 10.1158/1078-0432.CCR-08-0575.

4.

KIT mutations in ocular melanoma: frequency and anatomic distribution.

Wallander ML, Layfield LJ, Emerson LL, Mamalis N, Davis D, Tripp SR, Holden JA.

Mod Pathol. 2011 Aug;24(8):1031-5. doi: 10.1038/modpathol.2011.57. Epub 2011 Apr 8.

5.

KIT genetic alterations in anorectal melanomas.

Santi R, Simi L, Fucci R, Paglierani M, Pepi M, Pinzani P, Merelli B, Santucci M, Botti G, Urso C, Massi D.

J Clin Pathol. 2015 Feb;68(2):130-4. doi: 10.1136/jclinpath-2014-202572. Epub 2014 Nov 14.

PMID:
25398993
6.

BRAF and c-kit gene copy number in mutation-positive malignant melanoma.

Willmore-Payne C, Holden JA, Hirschowitz S, Layfield LJ.

Hum Pathol. 2006 May;37(5):520-7.

PMID:
16647948
7.

L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.

Antonescu CR, Busam KJ, Francone TD, Wong GC, Guo T, Agaram NP, Besmer P, Jungbluth A, Gimbel M, Chen CT, Veach D, Clarkson BD, Paty PB, Weiser MR.

Int J Cancer. 2007 Jul 15;121(2):257-64.

8.

Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.

Dai B, Cai X, Kong YY, Yang F, Shen XX, Wang LW, Kong JC.

Hum Pathol. 2013 Aug;44(8):1472-8. doi: 10.1016/j.humpath.2013.01.007. Epub 2013 Mar 22.

PMID:
23528861
9.

Genetic aberrations in primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS and BRAF in a series of 10 cases.

Langer R, Becker K, Feith M, Friess H, Höfler H, Keller G.

Mod Pathol. 2011 Apr;24(4):495-501. doi: 10.1038/modpathol.2010.220. Epub 2010 Dec 3.

10.

KIT pathway alterations in mucosal melanomas of the vulva and other sites.

Omholt K, Grafström E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK.

Clin Cancer Res. 2011 Jun 15;17(12):3933-42. doi: 10.1158/1078-0432.CCR-10-2917.

11.

Anorectal melanoma with a KIT-activating mutation, which is a target for tyrosine kinase inhibitor.

Itoh M, Goto A, Wakasugi H, Yoshida Y, Matsunaga Y, Fujii K, Suzuki K, Yonezawa K, Abe T, Arimura Y, Shinomura Y.

Int J Clin Oncol. 2011 Aug;16(4):428-34. doi: 10.1007/s10147-010-0139-5. Epub 2010 Nov 11.

PMID:
21069551
12.

BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level.

Helmke BM, Mollenhauer J, Herold-Mende C, Benner A, Thome M, Gassler N, Wahl W, Lyer S, Poustka A, Otto HF, Deichmann M.

Gastroenterology. 2004 Dec;127(6):1815-20.

PMID:
15578519
13.

KIT amplification and gene mutations in acral/mucosal melanoma in Korea.

Yun J, Lee J, Jang J, Lee EJ, Jang KT, Kim JH, Kim KM.

APMIS. 2011 Jun;119(6):330-5. doi: 10.1111/j.1600-0463.2011.02737.x. Epub 2011 Mar 24.

PMID:
21569090
14.

Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.

Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D.

Mod Pathol. 2009 Nov;22(11):1446-56. doi: 10.1038/modpathol.2009.116. Epub 2009 Aug 28.

15.

Tumour heterogeneity of mucosal melanomas during treatment with imatinib.

Schoenewolf NL, Urosevic-Maiwald M, Dummer R.

Br J Dermatol. 2011 Aug;165(2):419-24. doi: 10.1111/j.1365-2133.2011.10376.x.

PMID:
21495997
16.

C-kit expression of melanocytic neoplasm and association with clinicopathological parameters and anatomic locations in Chinese people.

Lin YC, Chang YM, Ho JY, Lin HC, Tsai YM, Chiang CP, Wang WM, Gao HW.

Am J Dermatopathol. 2013 Jul;35(5):569-75. doi: 10.1097/DAD.0b013e318279566a.

PMID:
23221472
17.

KIT gene mutations and patterns of protein expression in mucosal and acral melanoma.

Abu-Abed S, Pennell N, Petrella T, Wright F, Seth A, Hanna W.

J Cutan Med Surg. 2012 Mar-Apr;16(2):135-42.

PMID:
22513068
18.
19.

Sunitinib therapy for melanoma patients with KIT mutations.

Minor DR, Kashani-Sabet M, Garrido M, O'Day SJ, Hamid O, Bastian BC.

Clin Cancer Res. 2012 Mar 1;18(5):1457-63. doi: 10.1158/1078-0432.CCR-11-1987. Epub 2012 Jan 18.

20.

Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays.

Pache M, Glatz K, Bösch D, Dirnhofer S, Mirlacher M, Simon R, Schraml P, Rufle A, Flammer J, Sauter G, Meyer P.

Virchows Arch. 2003 Dec;443(6):741-4. Epub 2003 Sep 26.

PMID:
14513377
Items per page

Supplemental Content

Write to the Help Desk